The American Society for Microbiology (ASM), originally the Society of American Bacteriologists, is a professional organization for scientists who study viruses, bacteria, fungi, algae, and protozoa as well as other aspects of microbiology. It was founded in 1899. The Society publishes a variety of scientific journals, textbooks, and other educational materials related to microbiology and infectious diseases. ASM organizes annual meetings, as well as workshops and professional development opportunities for its members.
The National Institute of Allergy and Infectious Diseases is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.
An opportunistic infection is an infection caused by pathogens that take advantage of an opportunity not normally available. These opportunities can stem from a variety of sources, such as a weakened immune system, an altered microbiome, or breached integumentary barriers. Many of these pathogens do not necessarily cause disease in a healthy host that has a non-compromised immune system, and can, in some cases, act as commensals until the balance of the immune system is disrupted. Opportunistic infections can also be attributed to pathogens which cause mild illness in healthy individuals but lead to more serious illness when given the opportunity to take advantage of an immunocompromised host.
Group B streptococcal infection, also known as Group B streptococcal disease or just Group B strep, is the infection caused by the bacterium Streptococcus agalactiae. GBS infection can cause serious illness and sometimes death, especially in newborns, the elderly, and people with compromised immune systems.
The Infectious Diseases Society of America (IDSA) is a medical association representing physicians, scientists and other health care professionals who specialize in infectious diseases. It was founded in 1963 and is based in Arlington, Virginia. As of 2018 IDSA had more than 11,000 members from across the United States and nearly 100 other countries on six different continents. IDSA's purpose is to improve the health of individuals, communities, and society by promoting excellence in patient care, education, research, public health, and prevention relating to infectious diseases. It is a 501(c)(6) organization.
Clinical Microbiology Reviews is a peer-reviewed medical journal covering the areas of clinical microbiology, immunology, medical microbiology, infectious diseases, veterinary microbiology, and microbial pathogenesis. It is a delayed open access journal, full content is accessible via PubMed Central and the journal's website after a 12-month embargo. In April 2015, the journal transitioned to a continuous online publication model. The journal became online-only in January 2018. The final print issue was published in October 2017. According to the Journal Citation Reports, the journal has a 2021 impact factor of 50.129. The journal was established in January 1988. The founding editor was Josephine A. Morello. Editorial board structure changed in 1992 and Morello became editor-in-chief. Betty Ann Forbes was appointed editor-in-chief in 1997. Irving Nachamkin was appointed editor-in-chief in 2002 until 2012. Since 2012, Jo-Anne H. Young has served as editor-in-chief. It is the ninth journal established and published by the American Society for Microbiology.
Infection and Immunity is a peer-reviewed medical journal published by the American Society for Microbiology. It focuses on interactions between bacterial, fungal, or parasitic pathogens and their hosts. Areas covered include molecular pathogenesis, cellular microbiology, bacterial infection, host responses and inflammation, fungal and parasitic infections, microbial immunity and vaccines, and molecular genomics. The journal publishes primary research articles, editorials, commentaries, minireviews, and a spotlight report highlighting articles of particular interest selected by the editors. Articles are freely accessible after 6 months. Through its "Global Outreach Program," free online access is available to qualified microbiologists in eligible developing countries.
Clinical Infectious Diseases is a peer-reviewed medical journal published by Oxford University Press covering research on the pathogenesis, clinical investigation, medical microbiology, diagnosis, immune mechanisms, and treatment of diseases caused by infectious agents. It includes articles on antimicrobial resistance, bioterrorism, emerging infections, food safety, hospital epidemiology, and HIV/AIDS. It also features highly focused brief reports, review articles, editorials, commentaries, and supplements. The journal is published on behalf of the Infectious Diseases Society of America. The editor-in-chief is infectious disease physician Paul Sax.
The Journal of Infection is a monthly peer-reviewed medical journal in the field of infectious disease, covering microbiology, epidemiology and clinical practice. Established in 1979, the journal was initially published quarterly by Academic Press. The first editor was Hillas Smith. The Journal of Infection is the official publication of the British Infection Association. Since 2006, the editor-in-chief has been Robert C. Read and the publisher is Elsevier.
Infection is a bimonthly peer-reviewed medical journal published by Springer Science+Business Media. It covers research on infectious diseases, including etiology, pathogenesis, diagnosis, and treatment in outpatient and inpatient settings.
The Canadian Journal of Infectious Diseases and Medical Microbiology is a quarterly peer-reviewed medical journal. It is the official journal of the Canadian Association for HIV Research, for which it serves as the primary source of society guidelines. It is published by Hindawi Publishing Corporation and covers all aspects of infectious diseases and medical microbiology.
The Journal of Antimicrobial Chemotherapy is a peer-reviewed medical journal which covers antimicrobial chemotherapy, including laboratory aspects and clinical use of antimicrobial agents. It is published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy and was established in 1975. In January 2015 J. Peter Donnelly became the eighth editor-in-chief replacing Alan P. Johnson. The journal has had two previous publishers. All content is available for free after 12 months while authors also have the option to have their articles published immediately as open access.
The Association of Medical Microbiology and Infectious Disease Canada is a Canadian national medical specialty association composed of specialists in infectious diseases and medical microbiology, clinical microbiologists and researchers specializing in preventing, diagnosing, and treating infections. The association is a national specialty society recognized by the Royal College of Physicians and Surgeons of Canada. The association promotes the prevention, diagnosis, and treatment of human infectious diseases through our involvement in education, research, clinical practice and patient advocacy. Position papers and guidelines in support of this mission are published in the official Journal of the Association of Medical Microbiology and Infectious Diseases - JAMMI and/or posted on the organization's website. Prior to January 1, 2016, these were published in the Canadian Journal of Infectious Diseases and Medical Microbiology The annual meeting of the association occurs in the spring at which members present information of mutual interest.
The European Journal of Clinical Microbiology & Infectious Diseases is a monthly peer-reviewed medical journal covering clinical microbiology and infectious diseases. It was established in 1982 as the European Journal of Clinical Microbiology obtaining its current title in 1987. The founding editor was Ilja Braveny. The editor-in-chief is Laurent Poirel. It is published by Springer Science+Business Media.
Antimicrobial stewardship is the systematic effort to educate and persuade prescribers of antimicrobials to follow evidence-based prescribing, in order to stem antimicrobial overuse, and thus antimicrobial resistance. AMS has been an organized effort of specialists in infectious diseases, both in Internal Medicine and Pediatrics with their respective peer-organizations, hospital pharmacists, the public health community and their professional organizations since the late 1990s. It has first been implemented in hospitals. In the U.S., within the context of physicians' prescribing freedom, AMS had largely been voluntary self-regulation in the form of policies and appeals to adhere to a prescribing self-discipline until 2017, when the Joint Commission prescribed that hospitals should have an Antimicrobial Stewardship team, which was expanded to the outpatient setting in 2020.
The International Society for Infectious Diseases (ISID), established in 1986, is a nonprofit organization that monitors infectious diseases on a global scale. It also offers grants and fellowships, publishes a journal, and runs online learning platforms for sharing information on managing infectious diseases. It is based in Brookline, Massachusetts, US. The organization solicits donations from the general public, as well as governments, foundations, and the pharmaceutical industry.
The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) is a non-profit scientific international organization with headquarters in Basel, Switzerland. Its mission is to improve the diagnosis, treatment and prevention of infection-related diseases by promoting and supporting research, education, training, and good medical practice. An important activity of the society is the organization of the annual scientific congress ECCMID. This is recognized as the largest international forum for disseminating research in the fields of medical microbiology and infectious diseases for experts in academia, clinical settings and industry. The congress began as a biennial event, with about 1,500 participants at its inaugural occurrence in 1983. It became an annual event in the year 2000, and it has grown since then, now attracting around 14,000 participants annually. More than 5,000 scientific abstracts are submitted for inclusion each year by researchers from multiple countries. The most recent ECCMID was held online in April 2022 in a hybrid format, both online and onsite in Lisbon, Portugal.
Dimitrios P. Kontoyiannis is the Robert C Hickey Chair in Clinical Care and Deputy Head for Research in the Division of Internal Medicine at The University of Texas MD Anderson Cancer Center in Houston, Texas. He received his medical degree as valedictorian Summa Cum Laude from the National and Kapodistrian University of Athens, Greece. Kontoyiannis was trained in Internal Medicine at Baylor College of Medicine in Houston, where he served as a Chief Medical Resident. He was subsequently trained as a clinical fellow in Infectious Diseases at Massachusetts General Hospital and obtained a master's degree in Clinical Sciences from Harvard Medical School in Boston. He spent three years at the Whitehead Institute for Biomedical Sciences/Massachusetts Institute of Technology as a fellow in the Harvard MIT Clinical Investigators Training Program.
Müge Çevik is a physician who is an infectious diseases researcher and science communicator at the University of St Andrews. Her research considers HIV, viral hepatitis, emerging infections and tropical infections in developing countries. During the COVID-19 pandemic, Çevik was an advisor to the Chief Medical Officer of Scotland and the World Health Organization, and is a member of New and Emerging Respiratory Virus Threats Advisory Group - an expert committee of the UK Department of Health advising Scientific Advisory Group for Emergencies.
Hanan H. Balkhy is a Saudi physician who currently serves as the first Assistant Director of Antimicrobial Resistance at the World Health Organization.
